Network Meta-Analysis of Erlotinib, Gefitinib, Afatinib and Icotinib in Patients with Advanced Non-Small-Cell Lung Cancer Harboring EGFR Mutations

BACKGROUND: Several EGFR-tyrosine kinase inhibitors (EGFR-TKIs) including erlotinib, gefitinib, afatinib and icotinib are currently available as treatment for patients with advanced non-small-cell lung cancer (NSCLC) who harbor EGFR mutations. However, no head to head trials between these TKIs in mu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Liang, Wenhua, Wu, Xuan, Fang, Wenfeng, Zhao, Yuanyuan, Yang, Yunpeng, Hu, Zhihuang, Xue, Cong, Zhang, Jing, Zhang, Jianwei, Ma, Yuxiang, Zhou, Ting, Yan, Yue, Hou, Xue, Qin, Tao, Dinglin, Xiaoxiao, Tian, Ying, Huang, Peiyu, Huang, Yan, Zhao, Hongyun, Zhang, Li
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2014
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3922700/
https://ncbi.nlm.nih.gov/pubmed/24533047
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0085245
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados